SCHEMBL16307356

SCHEMBL16307356

CC1(C)c2ccccc2-c2cc3c4cc(-c5cccc(N(c6cccc(-c7ccccn7)c6)c6cccc(-c7ccccn7)c6)c5)ccc4n(-c4nc(-c5ccccc5)nc(-c5ccccc5)n4)c3cc21

nearest known ligand 0.33

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
▸ PDK2 Q15119 1/20 0.33
▸ ABL1 P00519 1/20 0.32
▸ BCR P11274 1/20 0.32
▸ BRD4 O60885 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL802629 0.92 PDK2 (0.38) PDK2BRD4
SCHEMBL17985345 0.92 — —
SCHEMBL19757752 0.90 — —
SCHEMBL19757748 0.90 — —
SCHEMBL19757782 0.88 — —
SCHEMBL802684 0.87 KDM1A (0.30) —
SCHEMBL17985383 0.87 KDM1A (0.30) —
SCHEMBL12181452 0.85 — —
SCHEMBL15133744 0.85 PDK2 (0.34) PDK2
SCHEMBL19757764 0.85 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10403833-B2 Organic metal complexes MERCK PATENT GMBH (DE) 2019-09-03 — — US disclosed
US-20170317298-A1 ORGANIC METAL COMPLEXES UDC IRELAND LIMITED (IE) 2017-11-02 — — US disclosed
US-20170317298-A1 ORGANIC METAL COMPLEXES UDC IRELAND LIMITED (IE) 2017-11-02 — — US disclosed
US-9748502-B2 Organic metal complexes MERCK PATENT GMBH (DE) 2017-08-29 — — US disclosed
US-9748502-B2 Organic metal complexes MERCK PATENT GMBH (DE) 2017-08-29 — — US disclosed
US-20140371825-A1 ORGANIC METAL COMPLEXES UDC IRELAND LIMITED (IE) 2014-12-18 — — US disclosed
US-20140371825-A1 ORGANIC METAL COMPLEXES UDC IRELAND LIMITED (IE) 2014-12-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10403833-B2 Organic metal complexes SOD1, ORC3, PPIA PDK2 1570/4885ABL1 1985/4885BCR 3897/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback